KRT5 and systemic sclerosis: Within both the IPF and SSc-ILD samples we identified a small population of the recently described aberrant basaloid cells (or KRT5-/KRT17+ cells), with no cells sharing this distinct transcriptome amongst the control samples (Figures 5A, B) (49, 50).